Development of membrane-permeable Aib-containing peptide for delivery of oligonucleotide drugs
Project/Area Number |
22590109
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Drug development chemistry
|
Research Institution | Osaka University of Pharmaceutical Sciences |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
URATA Hidehito 大阪薬科大学, 薬学部, 教授 (80211085)
|
Project Period (FY) |
2010 – 2012
|
Project Status |
Completed (Fiscal Year 2012)
|
Budget Amount *help |
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2012: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2011: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2010: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
Keywords | Aib / 膜透過性ペプチド / ヘリックス / 核酸医薬 / アンチセンス / 核酸医薬品 |
Research Abstract |
Oligonucleotide (ODN) drugs have interesting therapeuticpotentials in various biological applications. However, charged polar ODNs typicallyexhibit poor membrane permeabilization. My designed Aib-containing peptides showmembrane permeable properties, and have the potential for delivery of ODNs into cells.
|
Report
(4 results)
Research Products
(16 results)